The Ser(447)-Stop polymorphism of lipoprotein lipase is associated with variation in longitudinal serum high-density lipoprotein-cholesterol profiles: The Bogalusa Heart Study
Dm. Hallman et al., The Ser(447)-Stop polymorphism of lipoprotein lipase is associated with variation in longitudinal serum high-density lipoprotein-cholesterol profiles: The Bogalusa Heart Study, METABOLISM, 50(8), 2001, pp. 894-904
The Ser(447)-Stop polymorphism of lipoprotein lipase (LPL) has been associa
ted with altered high-density lipoprotein-cholesterol (HDL-C) and triglycer
ide (TG) levels at individual measurements, but nothing is known of its ass
ociations with lipid profiles derived from serial measurements. We used mul
tilevel statistical models to study effects of this polymorphism on longitu
dinal lipid profiles in 1,006 Bogalusa Heart Study subjects examined 4 to 9
times between the ages of 4 and 38 years. Stop(447) allele frequencies in
African Americans (0.053 +/- 0.011) and whites (0.091 +/- 0.009) differed s
ignificantly (chi (2) = 7.595, 1 df P = .006; Stop(447) homozygotes and het
erozygotes combined). Overall, TG levels were lower and HDL-G levels higher
in blacks than in whites of the same age and sex. Longitudinal TG profiles
were lower in Stop(447) carriers at all ages. However, longitudinal HDL-G
profiles differed among genotype groups with age: the Stop(447) allele was
associated with higher HDL-C only in subjects above approximately 10 years
of age. Genotype-specific HDL-G profiles also differed significantly among
race/sex groups. Thus, we found evidence of LPL genotype effects that vary
within individuals with age. Possible mechanisms, which could account for a
ge-related changes in the effects of LPL variants, are discussed. Copyright
(C) 2001 by W.B. Saunders Company.